Oncolix Inc. (fka ONCX)

[namtae]

Here's another great hire (sarcasm)

HOUSTON, TX / ACCESSWIRE / July 5, 2018 / Oncolix, Inc. (ONCX) (the "Company"), a biotechnology company focused on gynecological cancers, announced that Andrew Scott has joined the Company as its Vice President of Corporate Development. "Andrew is a seasoned veteran that understands the important roles of Investor Relations, banking relationships and raising capital," said Michael T. Redman, president and chief executive officer of Oncolix.

Let's see how he's doing:

Investor relations: ONCX now trading appx .01 after making new 52 week low of $0.0065 - Grade: FAILURE

Banking Relationships: Appears ONCX hasnt developed any new banking relationships that have been disclosed. Grade: FAILURE

Raising capital: Has ONCX raised any meaningful capital since this hire? Answer is NO!! Grade: FAILURE

Keep up the good work ONCX management team!! At least you're meeting my expectations!!